Headache Relief
- Product NDC
- 41250-334
- Requested package NDC
- 41250-334-08
- 11-digit product format
- 412500334
- Labeler code
- 41250
- Product ID
- 41250-334_746072ad-79e2-4d14-939d-d3c4396b47f2
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Acetaminophen, Aspirin, Caffeine
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Meijer Distribution Inc
- Application
- M013
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2008-03-13
- Substance
- ACETAMINOPHEN; ASPIRIN; CAFFEINE
- Active strength
- 250; 250; 65 mg/1; mg/1; mg/1
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 41250-334 | 41250-334-08 | D | Discontinued by firm | 2026-10-27 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Snapshot | Source SHA-256 |
|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | 557ba5c1ecfa… | 9c80585c8c6e… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Headache Relief
- Brand name suffix
- Extra Strength
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ACETAMINOPHEN | 250 mg/1 |
| ASPIRIN | 250 mg/1 |
| CAFFEINE | 65 mg/1 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 41250-334-08 | Headache ReliefExtra Strength | 1 in 1 CARTON | TABLET, FILM COATED | 1 | 18 | |
| 41250-334-08 | Headache ReliefExtra Strength | 24 in 1 BOTTLE, PLASTIC | TABLET, FILM COATED | 24 | 18 | |
| 41250-334-12 | Headache ReliefExtra Strength | 100 in 1 BOTTLE, PLASTIC | TABLET, FILM COATED | 100 | 18 | |
| 41250-334-12 | Headache ReliefExtra Strength | 1 in 1 CARTON | TABLET, FILM COATED | 1 | 18 | |
| 41250-334-15 | Headache ReliefExtra Strength | 50 in 1 BOTTLE, PLASTIC | TABLET, FILM COATED | 50 | 18 | |
| 41250-334-15 | Headache ReliefExtra Strength | 1 in 1 CARTON | TABLET, FILM COATED | 1 | 18 | |
| 41250-334-98 | Headache ReliefExtra Strength | 100 in 1 BOTTLE, PLASTIC | TABLET, FILM COATED | 100 | 18 | |
| 41250-334-98 | Headache ReliefExtra Strength | 2 in 1 CARTON | TABLET, FILM COATED | 2 | 18 |
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 41250-334 | HEADACHE RELIEF EXTRA STRENGTH (ACETAMINOPHEN, ASPIRIN, CAFFEINE) TABLET, FILM COATED [MEIJER DISTRIBUTION INC] | 17 | Current NDC, Legacy NDC, 8 package rows | 20241211_04f2c3ed-4bcf-4b6a-b8fb-0aa6ecb3dca2.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| good sense pain relief | ACETAMINOPHEN | Bryant Ranch Prepack | c226205d-7c3c-49af-b3e2-fc7b09ad7857 | 2025-02-05 | Warnings | M013 |
| Dye Free Childrens Acetaminophen | ACETAMINOPHEN | PAI Holdings, LLC dba PAI Pharma | a69fca9d-c0a0-4321-bf03-5c8e99cc07cc | 2025-02-04 | Warnings | M013 |
| TENSION HEADACHE RELIEF | ACETAMINOPHEN-CAFFEINE | TARGET CORPORATION | 8ed1679d-d3a1-11b1-e053-2995a90a61ad | 2025-01-31 | Warnings | M013 |
| ValuMeds Extra Strength Headache Relief | ACETAMINOPHEN, ASPIRIN, CAFFEINE | Cabinet Health P.B.C. | 0f864e73-e4b8-4e23-8990-8439ac17bd58 | 2025-01-31 | Warnings | M013 |
| Extra Strength Pain Reliever | ACETAMINOPHEN TABLETS 500 MG | WALGREENS | c25bfe92-0196-0489-e053-2995a90abea1 | 2025-01-30 | Warnings | M013 |
| Low dose Aspirin | ASPIRIN 81 MG DELAYED RELEASE TABLETS | WALGREENS | c25c3524-3e24-3410-e053-2995a90a73ed | 2025-01-30 | Warnings | M013 |
| HEADACHE RELIEF | ACETAMINOPHEN, ASPIRIN, CAFFEINE | WALGREENS | b5a45daa-05b1-4d6d-e053-2995a90a8444 | 2025-01-30 | Warnings | M013 |
| Aspirin 81 | ASPIRIN | WALGREENS | d71a571e-e2ce-7e0a-e053-2a95a90a53e0 | 2025-01-30 | Warnings | M013 |
| Regular strength aspirin | ASPIRIN | TARGET CORPORATION | e8c87ccb-8c0c-7830-e053-2995a90a88b7 | 2025-01-30 | Warnings | M013 |
| Multi-Symptom Menstrual Relief | ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE | TARGET | 2368ac1b-d644-9908-e063-6394a90a4b89 | 2025-01-29 | Warnings | M013 |
| Pain Reliever Extra Strength | ACETAMINOPHEN | Walgreen Company | 28e275fb-d615-4725-998c-946fe1bfdc0c | 2025-01-29 | Warnings | M013 |
| Childrens Acetaminophen | ACETAMINOPHEN | Major Pharmaceuticals | 38b839b6-de7d-4f33-a19a-efc92cdad92c | 2025-01-24 | Warnings | M013 |
| good sense pain relief | ACETAMINOPHEN | Preferred Pharmaceuticals Inc. | 523b68da-cd2a-4960-95e7-de5d51ce33c1 | 2025-01-23 | Warnings | M013 |
| Safety Coated Aspirin 81 mg Low Dose | ASPIRIN 81MG | Ulai Health LLC | 3d225a11-a53b-4dc2-9c25-13cab007900f | 2025-01-20 | Warnings | M013 |
| Pharbetol | ACETAMINOPHEN 325 MG | Ulai Health LLC | 55bb7e6c-e98c-48bd-b7bb-9848ff0273ca | 2025-01-20 | Warnings | M013 |
| ACETAMINOPHEN PM | ACETAMINOPHEN 500MG / DIPHENHYDRAMINE HCL 25MG | Ulai Health LLC | d4a568c9-a721-48d1-aebc-fc65444947ce | 2025-01-20 | Warnings | M013 |
| Pharbetol | ACETAMINOPHEN 500MG | Ulai Health LLC | c9d3cee1-531c-439f-ae19-07acd366aad6 | 2025-01-20 | Warnings | M013 |
| Percogesic Original Strength | ACETAMINOPHEN AND DIPHENHYDRAMINE HCL | Medtech Products Inc. | 529974c2-0121-4892-8e47-c2c447581091 | 2025-01-17 | Warnings | M013 |
| Little Remedies Childrens Fever Pain Reliever | ACETAMINOPHEN | Medtech Products Inc. | e1e44c85-d10c-4997-8f85-064cda7906eb | 2025-01-17 | Warnings | M013 |
| Stanback | ASPIRIN AND CAFFEINE | Medtech Products Inc. | caaa1313-09e4-45aa-8836-346f6a370196 | 2025-01-17 | Warnings | M013 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 308297 | acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG Oral Tablet | PSN | 04f2c3ed-4bcf-4b6a-b8fb-0aa6ecb3dca2 | 18 |
| 308297 | acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG Oral Tablet | SCD | 04f2c3ed-4bcf-4b6a-b8fb-0aa6ecb3dca2 | 18 |
| 308297 | APAP 250 MG / ASA 250 MG / caffeine 65 MG Oral Tablet | SY | 04f2c3ed-4bcf-4b6a-b8fb-0aa6ecb3dca2 | 18 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 41250-334-08 | 41250033408 | 1 BOTTLE, PLASTIC in 1 CARTON (41250-334-08) > 24 TABLET, FILM COATED in 1 BOTTLE, PLASTIC | 2008-03-13 | 0000-00-00 | No | No | Current |